Categories
Shares Small Cap

Nanosonics achieved a strong FY21 performance

Investment Thesis

  • Ultrasound disinfection is required. To avoid cross-infection, ultrasound transducers must be disinfected between patients. Trophon EPR outperforms traditional methods (soak, spray, wipe, or other manual reprocessing/disinfection methods). Traditional soaking, for example, takes 25 minutes, whereas Trophon disinfects ultrasound probes in 7-8 minutes.
  • Potential addressable installed base of 120,000 Trophon EPR units worldwide (40,000 each in the US, Europe, and the Rest of the World).
  • Higher level disinfection required to reinforce the drive path for new guidelines and regulations. New Guidelines in Australia and New Zealand for example, establish Trophon as the gold standard in high-level disinfection.
  • Trophon become standard of care and direct sales team driven for strong adoption as its continuous growing in North America.
  • With the demand for safety inventory, GE Healthcare has retained a large and credible distribution partner.
  • In the United Kingdom, the Managed Equipment Service (MES) business model is overcoming client capital budget constraints.
  • Progress is being made in terms of geographic expansion.
  • A strong balance sheet will help to support the growth strategy.

Key Risks

  • Increased competition as new entrance entered the market. 
  • Non-receptive markets where NAN’s product is regarded as excessive when compared to traditional disinfection methods such as using sterile wipes.
  • Key customer risk, as one of NAN’s largest customers
  • Product flaws or incidents that necessitate recalls.
  • Unfavorable foreign currency movements in the AUD/USD.
  • Poor R&D execution with no progress.
  • Because of the nature of the business, it is prone to quickly reaching a natural penetration rate, where growth becomes subdued.

FY21 results highlights

  • Revenue of $103.1m, up +3.0 percent (or +12 percent in constant currency), driven by recovery in 2H21 with revenue of $60.0m, up +39 percent (or +50 percent in CC) compared to 1H21.
  • NAN’s global installed base of 26,750 units increased by +13 percent or 3,030 units (with 2H new installed base increasing by +20 percent compared to 1H21 with 1,650 units installed).
  • Revenue of $76.4m, up +9% from 1H21 revenue of $42.7m, up +27% from 1H21, driven by a recovery in ultrasound procedure volume to pre-Covid-19 levels.
  • Operating profit before tax of $11.0m was -11 percent lower than the $12.4 m pcp, driven by 2H21 profit before tax $10.8m which grew as total revenue increase +39% in 2H21 versus 1H21.
  • NAN retained a strong balance sheet position to fund growth initiative with net cash position improving $4.2 to $96.0m.
  • Revenue of $26.7 million was down -11 percent, but 2H revenue of $17.3 million was up +84 percent compared to 1H21, with installed base growth recovering and GE Healthcare capital purchases increasing.
  • EBIT of $10.8 million fell -7 percent. Operating expenses increased by 12% to $70.8 million, primarily due to $20.3 million in 4Q expenses as NAN returned to its intended investment run rate.
  • The $5.9 million in free cash flow was driven by $8.3 million in 2H free cash flow, which offset a $2.4 million net cash outflow in 2H21.

Company Profile 

Nanosonics Ltd (NAN) is an ASX-listed company which focuses on developing and commercialising infection control devices. NAN’s first device, the trophon® EPR is a proprietary automated device for low temperature, high level disinfection of ultrasound probes. The device is approved for sale across major markets including, Australia and New Zealand, US, Europe, Japan, Hong Kong, and South Korea. The trophon® EPR is sold through distributors including GE Healthcare, Philips, Samsung, Siemens Toshiba and Miele Professional.

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Global stocks Shares

Ramsay Health Care reported solid earnings in fiscal year 2021

Investment Thesis :

  • Holds a leading positions in Australia, France and Scandinavia.
  •  Earnings will begin to rise in FY22-24 as a result of pent-up demand on waiting lists.
  •   Has a well-diversified portfolio with a large scale.
  • Australia’s largest private hospital operator, with strong industry fundamentals  
  • Favourable macro-industry trends include an ageing and growing population, the spread of chronic disease, and more innovation, treatment, and technology, all of which are driving demand to private hospital.
  • Supportive government policy (tax incentive for people to get private health insurance). 
  • Ongoing brownfield program driving earnings and offshore earnings growth
  • Significant international operation paves way for the firm to grow internationally in near future.
  •  Attractive industry dynamics with high entry barriers for new firms.

Key Risks:

  • Competitive risk (new hospitals, new beds), from listed and unlisted hospital operators
  • Brownfield projects fail to deliver the earnings uplift.
  • Cost pressures (negotiating price increases with private health insurance companies).
  • Government policy on private health insurance is changing.
  • Execution risk (able to get the uplift in earnings from brownfield projects).
  • Snap economic lockdowns due to Covid-19
  • Currency risk

Key financial highlights of year2021:

In relative to the previous corresponding period i.e pcp (herein pcp is year 2020)

  • During the year 2021, RHC revenue increased by 3.9% to $12.4bn.
  • The increase in revenue was driven by strong earning growth across all of its geographical segments-i.e from Asia Pacific, UK and Europe.
  • In Asia Pacific, revenue from patients increased by 7.8% to $5.4bn reflecting strong growth in surgical admission (2) In U.K, revenue increased by 10.2% to $1,024.1m and included payments from the NHSE of $417.6m representing net cost recovery for services provided by Ramsay to the NHSE during the year (3) Europe revenue increased by 6.9% to $6,839.9m and included government grants of $428.3m and was impacted by 80m euros from the sale of a portfolio of nine German hospitals in 1H21
  • EBIT increased by 29.1% to $1.1bn and statutory profit increased by 58.1% to $449m, reflecting a strong increase in admissions.
  • The Board declared a fully franked final dividend of 103cps, bringing the FY21 dividend to 151.5cps (up by 142.4 %) and representing a payout ratio of 79 percent of statutory profit.
  • During the underlying period ROCE improved by 60bps to 9.3% and ROIC gained by 260bps to 7%.
  • Operating cash flow fell by 11.9 % to $1.5 billion, owing to changes in working capital as a result of cash loans from the French government while FCF fell by 14.8 percent to $85,
  • Financial metrics improved, with net debt (excluding lease liabilities) fallen by 15 % to $2.4 billion, lowering leverage to 3.7 times from 4.4 times. 

Company Profile:

Ramsay Health Care Ltd (RHC) is a company that provides medical services. RHC has hospitals, day surgery centres, treatment facilities, rehabilitation centres, and psychiatric units all around the world. It has about 500 sites throughout Australia, the United Kingdom, France, Sweden, Norway, Denmark, Germany, Indonesia, Malaysia, Hong Kong, Italy, and the Nordic countries.

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Technology Stocks

Nitro software operating expenses rise as their top line expands

Investment Thesis

  • Total Addressable Market (TAM) for sizeable market opportunity is US$28bn (company estimates which is based on ground up model taking into account customer values). 
  • Created a solid foundation on which to build – the company has penetrated 68 percent of the Fortune 500 companies, and while the initial involvement with these companies may be small, it provides the opportunity to scale up with these customers (approx. 10 percent of the Fortunes 500 customers have 100 or more licenced users).
  • Structural tailwinds – businesses looking to digitise manual, paper-based processes are continuing to migrate online.
  • Looking to become a platform.
  • Subscription provides an appealing recurring revenue base.
  • The company’s competitive position continuously developing in R&D investment and enhance value proposition with customer.

Key Risks

  • Rising Competitive pressure especially when larger player like adobe inc and document sign.
  • Company trade on high valuation multiples like growth in subscriptions, new customers and Penetration of existing clients which disappoints the market growth.
  • Product Innovation stall and fails to resonate with customers.
  • Emergence of new competitors and technology.

Nitro software’s 1H CY21 result

  • Group revenue increased by +27 percent to $24.1 million, with subscription revenue increasing by +66 percent to $15.1 million as a result of new customer acquisition and growth among existing customers.  ARR (annual recurring revenue) of $33.8 million was up +56 percent Year on year.
  • Gross Profit was up 28 percent to US$22.1m, with Gross Profit margin of 92%.
  • R&D expenses of US$5.8m were up by 46% and represented 24% of revenue. Key Operating expenses saw significant increase as the company continuous to invest in the business to drive a top line growth.
  • Operating earnings (EBITDA excluding share-based and M&A expenses) were a loss of $3 million, compared to a gain of $0.2 million in the pcp.
  • At the end of the period, there was no debt and a cash balance of $38.6 million.

Company Profile 

Nitro Software Ltd (NTO), founded in 2005 & listed in 2019, is a global document productivity software company. NTO offers integrated PDF productivity, eSignature and business intelligence (BI) tools through a horizontal SaaS and desktop-based software suite. The Company helps customers move to 100% digital document workflows, eliminating paper and accelerating business processes.NTO serves customers around the world and counts 68% of the Fortune 500 companies among its customers. In total, NTO has over 12,000 business customers (who are defined as having at least 10 licensed users) and across 155 countries.

(Source: Banyantree)

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Shares Technology Stocks

Whispir’s strong FY21 results seems positive for the stock

Investment Thesis

  • Sizeable market opportunity – in the U.S. alone WSP TAM is US$4.7bn (WSP North American target markets) vs total U.S. CPaaS TAM of US$98bn.
  • Established a solid foundation to build from – the Company has over 800 customers worldwide with leading brand names.  
  • Structural tailwinds – ongoing automation and digitization. 
  • Increasing direct sales penetration.
  • Attractive recurring revenue base via subscriptions. 
  • Investment in R&D to continue developing the Company’s competitive position and enhance value proposition with customers.   

Key Risks

We see the following key risks to our investment thesis:

  • Rising competitive pressures.
  • Growth disappoints the market, given the company trades on high valuation multiples – growth in subscriptions, new customers and penetration of existing clients. 
  • Product innovation stalls and fails to resonate with customers. 
  • Emergence of new competitors and technology.
  • Key channel partnerships breakdown.

FY21 key trading metrics 

  • FY21 ARR (annualized recurring revenue) was up +28.5% to $53.6m, driven by increased spending by installed customer base and addition of new customers. Recurring revenue is now at 96.7%.
  • Customer revenue retention was 115.9%, with management noting that whilst customers may initially engage for single communication solutions, once implemented with operational processes, management find that new applications / use cases across client’s organization. 
  • Over the year, WSP added 171 net new customers (up +27% YoY), bringing total customer numbers to 801. An attractive component of WSP’s solution is the Company’s “low code-no code” platform, which easily integrates with existing inhouse client IT systems and can be deployed within hours. This is one of our key competitive advantages.
  • New customer acquisition costs were down more than 50% due to higher sales efficiency and a growing proportion of digital direct sales (self-discovering the platform). 
  • LTV / CAC (ratio of lifetime value to customer acquisition costs) improved to 26.1x (from 23.7x). 
  • Gross revenue churn (3 month average) at Jun-21 was 2.4%.

Company Description  

Whispir Ltd (WSP), founded in 2001, is a global enterprise software-as-a-service (SasS) company. WSP provides a communications workflow platform that automates interactions between businesses and people. The Company has over 800 customers, operates in 60 countries and more than 200 staff globally. WSP operates in an emerging subset of the enterprise communications SaaS market known as Workflow Communications-as-a-Service (WCaaS). WSP currently solves two communication problems: (1) Operational Messaging – engaging with employees; and (2) External Messaging – engaging with customers. WSP operates in 3 key markets – Operational messaging (size $8bn), API messaging (size $32bn) and Marketing messages (size $66bn).

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
ETFs ETFs

SPDR S&P/ASX200 Fund : A well diversified fund providing exposure to Australian market at low cost

Investment Objective:

The State Street SPDR S&P/ASX200 is the first ASX-listed ETF, launched in the year 2001.The SPDR S&P/ASX 200 Fund aims to closely match with the results of the S&P/ASX 200 Index before fees and expenses.

Investment strategy:

The fund aims to give exposure to core Australian stocks. The portfolio is well-diversified, covering approximately 90% of the Australian market in terms of capitalisation. The fund aims to provide both capital growth and income by investing in ASX-listed firms that are liquid. Herein, an investor can get diversified exposure to Australian share market at a low cost and yield performance of the 200 largest and most liquid publicly listed entities in Australia.

The entity responsible for the fund is State Street Global Advisors, Australia Services Limit.

Portfolio Objective:

  • Diversified exposure to Australian share.
  • Provides capital appreciation and growth if funds are invested over long term basis.
  • Provides adequate diversification to investors by investing in a single fund.

Fundamentals:

  • The size of the fund is $4.9bn and no. of holdings  in 203 shares of Australia.
  • The total market capitalization of the fund is AUD $2,196,388.80M as on 31/8/2021.
  •   Minimum subscription or redemption of 25,000 units is available to investor.
  • The fund provide an earnings growth of 10.66% and return on equity is 11.63%.
  • The equity (dividend) yield of the fund is 3.37% and its P/E ratio is 19.34.
  • Generally, the fund make distributions to investors on  quarterly basis.
  • The  management fee of the fund is 0.13%  p.a. of NAV.

Positives:

  • Diversification with low cost
  • Fast, flexible trading
  • Transparency

Negatives:

  • Failure to meet investment objective.
  • Exposure to various risk such as regulatory, credit, market, company,industry, derivative etc.
  • During the holding period the portfolio value may go up and down due to market volatility.

Company Profile:

State Street is a global asset manager and credited for creating the world’s first ETF and being an index pioneer.  Over the past forty years the company has built a universe of active and index strategies across asset classes to help investors achieve their goals.The company has $3.59 trillion asset under management, 23 million clients across 62 countries.

ETF Performance…

Figure 1: Fund performance as at 31 July 2021

(%)FundBenchmark
1-month+1.09%+1.10%
3-months+5.78%+5.80%
1-year+28.52%+28.56%
3-year (p.a.)+9.37%+9.48%
5-year (p.a.)+9.90%+10.05%
Since Inception (p.a.)+8.23%+8.54%

Source:State Street. 

ETF Positioning…

Figure 2: Top ten holdings

Source: State Street

   Figure3: Sector Allocation                       

     Source: State Street

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Technology Stocks

WiseTech declared strong FY21 results and uplift in dividends

Investment Thesis:

  • WiseTech is ahead of its nearest competitors, which clearly makes it a market leader
  • Increased globalization results in growing global trade, thereby accelerating selling of products 
  • Annual customer turnover rate is low and revenue visibility is high
  • Enhancement of WTC products evident from the amount spent on R&D 
  • WTC’s long term goal is to be the operating system for world-wide logistics 
  • After acquiring 39 companies since it got listed on stock exchange in 2016, WTC has built up substantial resources and development capabilities to drive its CargoWise technology pipeline.
  • The scalability of WiseTech business model  
  • Due to higher consolidation of the logistics software industry, geopolitical tensions are considered as tailwinds by management 

Key Risks:

  • Another earnings downgrade is announced by the company
  • Organic growth could narrow down further, which might not result in such high valuation. Although, organic growth was improved during FY19.
  • Management has observed that the revenues from recent acquisitions have declined indeed and rendered very less margin. This means that the return obtained from these acquisitions could take longer than management’s expectations
  • Threats from competition like new product/technological advancements
  • Disruption caused due to technology (data breach)
  • Currency moving adversely

Key Highlights:

  • Share price of WiseTech Global Ltd (WTC) rose by 28.5% after its announcement of FY21 results which is higher than market estimates and the Company’s own expectation. 
  • Strong uplift in dividend payments has also been declared
  • Total Revenue for FY21 is $507.5m, which is up by +18% (or +24% ex FX)
  • EBITDA of $206.7m, is up by +63% in comparison to FY20
  • FY21 NPAT is $105.8m, which was up by +101% with reference to FY20
  • Investment of $167.1m by WTC in Research and Development (up from $159.1m in FY20), which is about 33% of total revenue, ensures that WTC stay ahead of its competitors
  • Management announced a strong FY22 outlook, expecting revenue growth of 18% – 25% and EBITDA growth of 26% – 38% 

Company Profile:

WiseTech Global (WTC) which was founded in October 1994, is a leading provider of software to the logistics services industry globally. WTC develops, sells and implements software solutions that enable logistics service providers to facilitate the movement and storage of goods, domestically and internationally. WTC’s software assists their customers to better address and adapt to the complexities of the logistics industry while increasing their productivity, reducing costs and mitigating risks. WTC services over 6,000 customers across more than 115 countries with offices in Australia, New Zealand, China, Singapore, South Africa, United Kingdom and the United States. 

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Shares Technology Stocks

Another Strong Quarter for Zoom with Steeper Q4 Deceleration in Guidance

However, third-quarter guidance was mixed but largely in line and implied fourth-quarter guidance shows a steeper deceleration in top line growth than anticipated as a result of increasing churn and lower customer’s additions in the online channel that focuses on smaller customers. 

Zoom has been guiding to deceleration as the year progresses, even as it has been beating expectations and raising full year expectations over the last three quarters. There is a long runway for growth as the company gains traction with Zoom Phone and evolves its main application to a communication platform. Along these lines, management will focus on expanding its platform to feature a wider array of revenue generating products as hyper growth normalizes.

Current remaining performance obligations, or cRPO, grew 58% year over year in the quarter, compared with 54% revenue growth. While this is generally a positive indicator for revenue over the next year, management was careful to point out that billings cycles are growing increasingly concentrated in the April quarter and that therefore both cRPO and deferred revenue are to decrease sequentially in the third quarter.

Company’s Future outlook

Zoom Vedio Communication’s last traded price was 347.50 USD, whereas its fair value estimate is 252.00 USD, which makes it a highly overvalued stock.  Revenue grew 54% year over year to $1.021 billion, which topped the high end of guidance of $990 million. Direct and channel business was strong, with enterprise customers doing larger deals but taking more time to evaluate the solution and being more strategic in their approach. Up sells of Zoom Phone and a pickup in Zoom Rooms helped drive larger deals. New customers accounted for 74% of revenue, which is unusually high for a software company of Zoom’s size. Zoom Phone momentum continued during the quarter, with the company reaching 2 million seats. Net dollar expansion remains strong at 130%,

Company Profile

Zoom Video Communications provides a communications platform that connects people through video, voice, chat, and content sharing. The company’s cloud-native platform enables face-to-face video and connects users across various devices and locations in a single meeting. Zoom, which was founded in 2011 and is headquartered in San Jose, California, serves companies of all sizes from all industries around the world.

(Source: Morningstar)

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Shares Small Cap

InvoCare Headwinds with the Return of Funeral Restrictions Immaterial to FVE

The company boasts well-known, highly respected brands and cost advantages over the long tail of smaller players in the highly fragmented death care industry, underpinning our wide economic moat rating. Death is one of few certainties in life, supporting steady demand for InvoCare’s services. Death rates can fluctuate from year to year. For instance, social distancing and increased hygiene focus in the wake of the COVID-19 pandemic led to a virtually non-existent flu season and significantly lower mortality rates in calendar 2020. However, death rates are very consistent over the long run.

While the program created some near-term disruption as venues closed or were otherwise impaired while undergoing refurbishments, InvoCare to capture an increasingly large portion of market share, given its dominant position, brand strength, and refreshed service offering following the venue refurbishments. Customers, typically the family of the deceased, are relatively price-insensitive, given the highly emotional context surrounding death care. 

Financial Strength 

InvoCare’s balance sheet is in a strong position following the AUD 274 million equity raising in calendar 2020. Leverage, measured as net debt/adjusted EBITDA, improved to 1.3 at fiscal year-end 2020, from 2.4 in fiscal 2019, comfortably below covenant levels of around 3.5. As earnings improve, net debt to fall below 1.0 times EBITDA by fiscal 2022. Underlying operating income lifted 46% on the coronavirus-ravaged prior corresponding period, or PCP, to AUD 39 million, still around 10% below the first half of fiscal 2019. Pricing bounced back during the period as restrictions on funeral attendances eased and pricing recovered—a demonstration of the strength of the underlying business.

Australia’s hardline approach to minimising COVID-19 cases with social distancing, lockdowns, and an increased focus on hygiene is leading to the second consecutive year of virtually no flu. InvoCare’s Australian funeral volumes in the first half were flat on the prior corresponding period and down approximately 3% on the prepandemic first half of fiscal 2019. The number of deaths to grow at an average CAGR of around 3% per year for the next decade, accelerating beyond 2030 due to demographics. The last traded price of Invocare Ltd was 12.15 AUD while it’s Fair Value Estimate 15.30 AUD which shows that InvoCare has potential to Grow.

Bulls Say’s

  • InvoCare consistently generates return on invested capital above its weighted average cost of capital, reflective of its pricing power due to its market position, reputation, and strong brand equity.
  • Industry volumes are immune to economic factors and will steadily grow as the population increases.
  • Prepaid funerals effectively lock in future sales and provide InvoCare with a low-cost source of funding.

Company Profile 

InvoCare is the largest funeral, cemetery, and crematorium operator in Australia and New Zealand. We estimate InvoCare enjoys over a third of revenue share in Australia, and around a fifth in New Zealand, and is the number one player in both countries. Australia contributes the vast majority of consolidated earnings. InvoCare owns a portfolio of over 60 brands, including three flagship national Australian brands: White Lady, Simplicity Funerals, and Value Cremations, and owns and operates 290 funeral homes, along with 16 cemeteries and crematoria. 

(Source: Morningstar)

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Fixed Income Fixed Income

Westpac Banking Corp to issue Convertible perpetual notes

Investment Thesis:

  • For WBCPK, the final distribution margin has been decided at 2.9%, which is more than BBSW (Bank Bill Swap Rate) in comparison to pre-book build range of 2.9- 3.1%.
  • The WBCPK securities are similar to the value declared by the recently offered MBLPD (Macquarie Bank Ltd.) securities but offer a healthy premium margin to other major banks’ AT1 securities.
  • WBCPK offers a gross running yield of 2.0% and yield-to-first call maturity of 4.1%.
  • Westpac Bank has a powerful business and is a regular issuer of debt- instrument in the market.
  • Westpac is also offering an opportunity to reinvest (“Reinvestment Offer”) into the new WBCPK securities to all current WBCPG (Westpac Capital Notes 4) holders since the first call date (20 Dec-21) of WBCPG is approaching. 
  • WBCPG investors have been given the option of reinvesting some or all of their holdings into WBCPK. If WBCPG investors hold it until 20 Dec-21, Westpac has disclosed that the Company plans to redeem any outstanding notes for face value of $100 per security.

Key Risks:

  • The current market price of WBCPK would be volatile on account of different factors that may impact the financial and economic conditions. Interest Rate is likely to fluctuate along with the change in the market rate.
  • Economic distress to the Australian economy, including an extended declining phase in the Australian economy. 
  • Risk of dividends not being paid, given that they are discretionary.
  • WBCPK are anticipated to be converted into ordinary shares on the Scheduled Conversion Date, unless mentioned otherwise on or before that date. 
  • Risk of non-occurrence of conversion on the scheduled conversion date because of the inability of fulfilment of the scheduled conversion conditions due to a large fall in the Ordinary Share price relative to the Issue Date VWAP (Volume Weighted Average Price), or if ordinary shares stop from being quoted on ASX or have been limited from trading for a specific period.
  • The price of the Ordinary Shares may be impacted by transactions affecting the Westpac Bank share capital, such as rights issues.
  • Westpac Bank’s financial performance and position may affect the market price of WBCPK (and the ordinary shares into which they are expected to be converted).

Security Description:

WBCPK securities are fully paid, non-cumulative, convertible, redeemable, perpetual, and unsecured, which is subject to a capital trigger event and non-viability trigger event, subordinated, listed securities. Its current price is $100 and the coupon rate that it would be offering would be 2.90%. Its issue date is 15th September, 2021. The securities have been scheduled to be converted into ordinary shares on 21 June 2032 (only on account of conversion conditions being fulfilled). 

Company Profile:

Westpac is one of Australia and New Zealand’s leading financial services provider, operating under multiple brands, with a low presence in Europe, North America and Asia.  As on 31st March 2021, Westpac and its controlled entities had total assets of approximately $889 billion. 

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
ETFs ETFs

Vanguard Australian Shares Index ETF offers potential long-term capital growth with dividend income

Investment Objective

Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

Investment Strategy

The fund provides low cost and efficient exposure to the broad Australian share market.  The fund offers diversification by being exposed to all market sectors including the AREITs. The fund seeks to generate capital growth over the long term while producing dividend income along the way attached with franking credits.  

Portfolio Objective

  • Competitive long-term returns while less exposed to volatility in the price of any one security.
  • Deliver long term returns at low cost. 
  • The fund seeks long term capital growth, tax effective income while being tolerant to share market volatility.  

Positives

  • Diversification.
  • Low cost exposure to a broad and diverse range of listed securities. 
  • Quarterly distributions. 

Negatives 

  • Share market volatility could cause the portfolio value to go up and down during the holding period.  
  • The index tracking capability of the fund may fail to meet the objectives of the fund.
  • The fees and costs of the fund may change.

Company Description 

The Vanguard Group has been in Australia since 1996 and currently has $140 billion of assets under management. The Group manages some 82 funds with head office in Melbourne, Australia. The Vanguard Group, globally, has been operating since 1975 with $1.6 trillion of asset under management. The global group manages 400 funds with 30 million investors worldwide.

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.